Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response

BACKGROUND: Real time PCR has become the most common technique to monitor BCR-ABL transcript levels of patients treated with kinase inhibitors. The aim of this study was to evaluate BCR-ABL levels of chronic myeloid leukemia patients treated with imatinib in the chronic phase and correlate the respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Melissa Pereira, Tomaz, Juarez Pires, Lorand-Metze, Irene, de Souza, Cármino Antonio, Vigorito, Afonso Celso, Delamain, Marcia Torresan, Bendit, Israel, Pereira, Noemi Farah, Pagnano, Katia Borgia Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415739/
https://www.ncbi.nlm.nih.gov/pubmed/23049298
http://dx.doi.org/10.5581/1516-8484.20110056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415739/
https://www.ncbi.nlm.nih.gov/pubmed/23049298
http://dx.doi.org/10.5581/1516-8484.20110056

Ejemplares similares